A review of the safety of interleukin-17A inhibitor secukinumab
V Eshwar, A Kamath, R Shastry, AK Shenoy, P Kamath - Pharmaceuticals, 2022 - mdpi.com
Secukinumab is an anti-interleukin (IL)-17A IgG1-κ monoclonal antibody approved for
psoriasis, psoriatic arthritis, and ankylosing spondylitis. Its efficacy is well documented, but …
psoriasis, psoriatic arthritis, and ankylosing spondylitis. Its efficacy is well documented, but …
The safety of brodalumab for the treatment of psoriasis
Introduction: Brodalumab is a newly developed targeted biologic agent for the treatment of
psoriasis that blocks IL-17 receptor A. Areas covered: This review sought to provide a …
psoriasis that blocks IL-17 receptor A. Areas covered: This review sought to provide a …
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast …
L Li, J Liu, M Xu, H Yu, C Lv, F Cao, Z Wang, Y Fu… - Cell Death & …, 2020 - nature.com
This study aimed to evaluate treatment response, survival, safety profiles, and predictive
factors to chimeric antigen receptor T cell (CAR-T) therapy in Chinese patients with relapsed …
factors to chimeric antigen receptor T cell (CAR-T) therapy in Chinese patients with relapsed …
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders
P Ruscitti, A Conforti, P Cipriani… - Advances in …, 2021 - SciELO Brasil
As the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) continues to spread rapidly, there are still many …
syndrome coronavirus 2 (SARS-CoV-2) continues to spread rapidly, there are still many …
A systematic overview of contraindications and special warnings for biologic and targeted synthetic disease modifying antirheumatic drugs: establishing a framework …
L Skaarup, E Ingrid, A Sepriano, E Nikiphorou… - Drug Safety, 2024 - Springer
Abstract Background/Aim The purpose of this review is to provide an overview of the
contraindications, special warnings, and boxed warnings with the aim to establish a …
contraindications, special warnings, and boxed warnings with the aim to establish a …
[HTML][HTML] Global risk of bacterial skin infections and herpesviridae infections with ustekinumab, secukinumab, and tumour necrosis factor-alpha inhibitors: spontaneous …
L Davidson, JMPA Van den Reek… - Acta Dermato …, 2022 - ncbi.nlm.nih.gov
Abstract Genetic defects in interleukin-12/23/17 immunity are associated with an increased
risk of Staphylococcus aureus and herpesvirus skin infections. This study analysed …
risk of Staphylococcus aureus and herpesvirus skin infections. This study analysed …
Anti-Herpes zoster vaccination in patients with dermatologic diseases: A position statement from the Italian SIDeMaST group of sexually transmitted, infectious and …
G Ciccarese, F Drago, A Herzum, L Atzori… - Italian Journal of …, 2024 - iris.unica.it
Herpes zoster (HZ) is a condition caused by the reactivation of varicella-zoster virus (VZV),
the virus responsible for chickepox, which is the clinical manifestation of the primary …
the virus responsible for chickepox, which is the clinical manifestation of the primary …
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States
D Singer, P Thompson-Leduc, S Ma… - … : Targets and Therapy, 2024 - Taylor & Francis
Purpose Patients with psoriasis (PsO) and psoriatic arthritis (PsA) are at increased risk of
herpes zoster (HZ), but healthcare resource use (HRU) and costs relating to HZ in adults …
herpes zoster (HZ), but healthcare resource use (HRU) and costs relating to HZ in adults …
[HTML][HTML] Il-17 in skin infections and homeostasis
MG García-Patiño, MC Marcial-Medina… - Clinical …, 2024 - Elsevier
Interleukin (IL) 17 is a proinflammatory cytokine belonging to a structurally related group of
cytokines known as the IL-17 family. It has been profoundly studied for its contribution to the …
cytokines known as the IL-17 family. It has been profoundly studied for its contribution to the …
Incidence, risk factors, and consequences of human alphaherpesvirus infections in patients with psoriasis who initiate methotrexate or biologic agents
O Rezahosseini, MS Liljendahl, N Loft… - The Journal of …, 2022 - academic.oup.com
Background Immunosuppressive agents may increase the risk of infections with human
alphaherpesviruses. Methods We included all adult patients with moderate to severe …
alphaherpesviruses. Methods We included all adult patients with moderate to severe …